Clinical trials
Completed Observational Sleep Deprivation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beddit.com Ltd | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Cairo University | 1 |
| Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 1 |
| China Medical University, China | 1 |
| Chinese University of Hong Kong | 1 |
| Claude Bernard University | 1 |
| Dayzz Live Well Ltd. | 1 |
| Federal University of São Paulo | 1 |
| Groupe de Recherche sur le Handicap Respiratoire | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Deprivation | 31 |
| Cardiovascular Diseases | 2 |
| Chronobiology Disorders | 2 |
| Cognitive Dysfunction | 2 |
| Diabetes Mellitus | 2 |
| Fatigue | 2 |
| Restless Legs Syndrome | 2 |
| Sleep Apnea Syndromes | 2 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Sleep Wake Disorders | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.